Sponsored
Dr Reddy's receives two USFDA observations for New York API facility
Posted
Dr. Reddy's Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025. The company will address these concerns within the given timeframe.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
‘Most iconic moment’: One year of Trump’s assassination attempt at Butler; ‘cascade of preventable failures’, says Senate committee
US President Donald Trump attended a soccer match with his family. The match coincided with the...